Paragon Biosciences works with some of the top healthcare industry leaders to deliver speed and efficiency when it comes to getting medicine to patients. Paragon is equipped with advanced resources as well as cutting-edge strategy, support, and guidance in order to support the healthcare industries and in turn they can help the patients (Worldbusinesschicago). They conduct all of the clinical trials and development of the medicine with some of the best medical professionals in the business.
In little under five years, they have had thirteen medicines FDA approved in order to be given to the patients with the most need. How does it work? Paragon Biosciences has a simple three-step process.
First, they identify diseases with the most need for an approved medicine as well as finding locations with the least treatment available to those patients with the disease. Second, they build a portfolio for the research and to create capital to attract investors and maintain a model. Finally, they develop the drug to bring it to market and have had a rapid advance rate so far in having these drugs approved.
Jeff Aronin is the chairman and CEO of Paragon Biosciences. He first started in the business nearly 20 years ago when he founded Ovation Pharmaceuticals that lead to great success. Mr. Aronin’s experience not only in healthcare but in complex science, rare diseases, and drug development has made him one of the most thriving and innovative leaders in the bioscience sector (https://www.bloomberg.com/research/stocks/private/person.asp?personId=2146317&privcapId=215356084).
Jeff Aronin’s passion for healthcare gives him the dedication to find and bring in talented teams of scientists and business executives under one roof to research many of the drug treatments that are used today. Jeff also serves as a mentor to many, not only researching and developing needed treatments but sharing his experience with up and coming entrepreneurs looking to grow in the field.